Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer
Journal of Oncology Pharmacy Practice
Published online on May 06, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionUp to 60% of adults with metastatic colorectal cancer (mCRC) receiving combination cytotoxic chemotherapy may experience loss of skeletal muscle mass and function. This study explores associations of artificial intelligence (AI)-based skeletal ...
IntroductionUp to 60% of adults with metastatic colorectal cancer (mCRC) receiving combination cytotoxic chemotherapy may experience loss of skeletal muscle mass and function. This study explores associations of artificial intelligence (AI)-based skeletal ...